Target intelligence / Profile preview

Gastric luminal hydrogen ion (H+)

Target
H+
Molecular classification
Inorganic ion, Cation, Electrolyte
01

Overview

Gastric luminal hydrogen ions, commonly referred to as gastric acid, are secreted by the parietal cells of the stomach lining via the H+/K+ ATPase pump [2]. These ions create a highly acidic environment (pH 1.5 to 3.5) essential for the denaturation of dietary proteins and the conversion of pepsinogen into the active proteolytic enzyme pepsin [2]. Beyond digestion, the acidic environment serves as a critical physiological barrier against ingested pathogens [2]. However, excessive accumulation or reflux of these ions into the esophagus can lead to mucosal damage, resulting in conditions such as gastroesophageal reflux disease (GERD) and peptic ulcers [4]. While many drugs like proton pump inhibitors (PPIs) and H2-receptor antagonists reduce the production of these ions, antacids act by directly neutralizing the existing luminal H+ through chemical reactions [1]. This neutralization provides rapid symptomatic relief by increasing the gastric pH and reducing the corrosive effect of the acid on the gastrointestinal mucosa [1, 3].

Other names
Gastric acidStomach acidGastric H+Hydronium ionGastric lumenal H+
02

Mechanism of action

Direct chemical neutralization of gastric acid to increase luminal pH, thereby reducing the acidity of the gastric contents [1].

03

Biological functions

Protein denaturationPepsinogen activationAntimicrobial defenseNutrient absorption (e.g., Vitamin B12, Iron)
04

Disease associations

Gastroesophageal reflux disease (GERD)Peptic ulcer diseaseGastritisZollinger-Ellison syndromeDyspepsia
05

Safety considerations

Metabolic alkalosisMilk-alkali syndromeConstipation (aluminum-containing agents)Diarrhea (magnesium-containing agents)Drug-drug interactions due to altered gastric pH
06

Interacting drugs

Aluminum hydroxide

3 more in the full profile.

07

Biomarkers

Gastric pHEsophageal pH monitoring

Beyond the preview

Go deeper on Gastric luminal hydrogen ion (H+).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gastric luminal hydrogen ion (H+).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call